|
Vascular Biology and Hypertension Research Program |
 |
 |
|
The Vascular Biology and Hypertension Program focuses on molecular and cellular approaches to important problems in cardiovascular medicine. Active in clinical trials include novel therapeutic agents for hypertension, dyslipidemia, diabetes/insulin resistance and obesity.
Program Director
Suzanne Oparil, MD
Related Information
Vascular Biology & Hypertension Fellowship
Vascular Biology & Hypertension Program Website
|
|
Types of Research
|
- Clinical
- Translational
- Basic
|
|
Focus
|
Fundamental aspects of hypertension and vascular biology research. Ongoing investigations include assessment of:
- the role of inflammation in the response to acute vascular injury and its modulation by sex hormones and peptide mimetics of high density lipoprotein (HDL) cholesterol
- the role of natriuretic peptide signaling and mineralocorticoid receptor antagonism in protecting against adverse remodeling in the pressure-overloaded heart
- the molecular pathogenesis of hypoxic pulmonary hypertension and pulmonary vascular remodeling
- novel approaches to the treatment of resistant hypertension and atherosclerotic disease
In addition, the Program is active in clinical trials of novel therapeutic agents for hypertension, dyslipidemia, diabetes/insulin resistance and obesity.
|
|
Methods
|
Cellular and molecular approaches to the study of cardiovascular control mechanisms. |
|
Collaborations
|
- Anesthesiology
- Medicine
- Pathology
- Physiology & Biophysics
- Surgery
|
|
Contact Information
|
Suzanne Oparil, MD
Email Address:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Pam Jacobs, Office Administrator
Email Address:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Zeigler Research Building, Room 1034
703 19th Street South
Birmingham, Alabama 35294-0007
Office Phone: (205) 934-2580
Office Fax: (205) 975-5119
|
Top
|
|
